3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Other solid neoplasm
1
Conditions
Lung Diseases
2
Respiratory Aspiration
1
Pulmonary Atelectasis
1
Pneumothorax
1
Pleural Neoplasms
1
Pleural Effusion, Malignant
1
Pleural Diseases
1
Pericardial Effusion
1
Mesothelioma, Malignant
1
Lung Neoplasms
1
Hemothorax
1
Empyema, Pleural
1
Interventions
Carboplatin
509
Cisplatin
410
Pemetrexed
399
Radiotherapy
282
Docetaxel
244
Paclitaxel
227
pembrolizumab
225
Gemcitabine
198
Drug Therapy
191
Bevacizumab
190
Erlotinib Hydrochloride
189
Radiosurgery
176
Nivolumab
168
Etoposide
155
durvalumab
154
osimertinib
126
atezolizumab
109
Gefitinib
96
Blood Specimen Collection
93
Vinorelbine
90
Magnetic Resonance Spectroscopy
90
anlotinib
88
Surgical Procedures, Operative
85
Ipilimumab
62
Immunotherapy
62
Surveys and Questionnaires
60
sintilimab
59
Specimen Handling
59
tislelizumab
58
Irinotecan
57
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
One-Lung Ventilation
×
Thoracic
×
Clear all
NCT00534690
2026-05-15
REVOLU
University Hospital, Bordeaux
Phase NA
Completed
88 enrolled
NCT05077111
2021-10-14
VATS
Ain Shams University
Phase 4
Unknown
40 enrolled